1[1]Staffa JA, Jones J K, Gable CB, et al. Risk of selected serious cardiac events among new users of antihistamines [J]. Clinical Therapeutics, 1995,17:1062.
2[2]Verspeelt,Amery WK. Non-sedating anti-histamines and ventricular arrhythmias: An analysis in the Mediplus-General Practitioner Database [J]. Eur J Clin Pharmacol, 1997,52: 315.
3[3]Lindquist M, Edwards IR. Risk of nonsedating antihistamines [J]. Lancet,1997,394: 1322.
4[4]Crumb WJ. The blocking effect of loratadine on human cardiac K+ channel [J]. J Pharmacol Exp Ther, 2000,292: 261.
5[5]Passalacqua G, Bousquet J, Bachert C, et al. The clincal safety of H1-receptor antagonists[J]. Allergy, 1996,51: 666.
